Latest Conference Articles

Evaluating long-term safety of micro-bypass implant with phaco in PXG

Evaluating long-term safety of micro-bypass implant with phaco in PXG

December 12th 2020

AAO

Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.

Visual and non-visual benefits of violet light-filtering IOLs

Visual and non-visual benefits of violet light-filtering IOLs

December 10th 2020

AAO

Daniel H. Chang, MD, speaks on the highlights of his presentation on "Violet Light-Filtering IOLs: Visual and Non-Visual Benefits," during the virtual AAO 2020 meeting.

Drug delivery vs drops: Controlling postop pain, inflammation in cataract surgery patients

Drug delivery vs drops: Controlling postop pain, inflammation in cataract surgery patients

December 8th 2020

AAO

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.

Single administration of intracameral bimatoprost implant: IOP lowering, safety

Single administration of intracameral bimatoprost implant: IOP lowering, safety

December 2nd 2020

AAO

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

December 1st 2020

AAO

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

(AAO) Comparing outcomes of xen gel stents in glaucoma practice

(AAO) Comparing outcomes of xen gel stents in glaucoma practice

November 28th 2020

AAO

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.

AAO official voices optimism for future of health care with incoming Biden admin

AAO official voices optimism for future of health care with incoming Biden admin

November 22nd 2020

AAO

During AAO 2020, Cathy G. Cohen, MHSA, CAE, AAO vice president for governmental affairs, offered some optimism for the future of health care under the Biden administration.

Virtual AAO Museum of the Eye event kicks off November 18

Virtual AAO Museum of the Eye event kicks off November 18

November 17th 2020

AAO

A unique Behind-the-Scenes series from the American Academy of Ophthalmology Truhlsen-Marmor Museum of the Eye kicks off November 18, from noon to 1 pm Pacific, with “The National Trachoma Service.” Register now for this event.

(AAO) Study outlines use of injectable intraocular steroid over drops

(AAO) Study outlines use of injectable intraocular steroid over drops

November 16th 2020

AAO

Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.

(AAO) Fingolimod for MS offers disease control with no development of uveitis

(AAO) Fingolimod for MS offers disease control with no development of uveitis

November 15th 2020

AAO

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.